Cross-transmission studies with Eimeria arizonensis-like oocysts (Apicomplexa) in New World rodents of the Genera baiomys, Neotoma, Onychomys, Peromyscus, and Reithrodontomys (Muridae).

Cross-transmission experiments were performed using oocysts of an Eimeria arizonensis-like coccidian from Peromyscus leucopus and Peromyscus truei, an E. arizonensis-like coccidian from Reithrodontomys fulvescens, Eimeria baiomysis and Eimeria taylori from Baiomys taylori, Eimeria albigulae from Neotoma albigula, and Eimeria onychomysis from Onychomys spp., between representatives of the above host genera. The E. arizonensis-like coccidian from R. fulvescens infected Reithrodontomys megalotis, Reithrodontomys montanus, and Peromyscus leucopus. Oocysts of E. arizonensis from P. leucopus could be transmitted to both P. leucopus and R. megalotus. Oocysts of E. baiomysis and E. taylori infected only B. taylori. Oocysts of E. arizonensis from P. truei infected P. truei but not Neotoma mexicana or Onychomys leucogaster. Oocysts of E. albigulae from N. albigula were infective for N. mexicana but not for P. truei or O. leucogaster. Oocysts of E. onychomysis from Onychomys spp. infected O. leucogaster but not N. mexicana or P. truei. These results demonstrate that Peromyscus and Reithrodontomys, genera known to be related very closely evolutionarily, are capable of sharing E. arizonensis, whereas morphologically similar coccidians (E. albigulae, E. baiomysis, and E. onychomysis) from more distantly related hosts, are probably distinct and more stenoxenous. This also is the first report of coccidians infecting species of Reithrodontomys.

Enzyme variation of Eimeria arizonensis from Peromyscus truei and P. boylii.

Cricetid rodents, Peromyscus truei and P. boylii, were inoculated with sporulated oocysts of Eimeria arizonensis collected from wild P. truei maintained in the lab. In P. truei the prepatent period was 4-5 days, the patent period was 9-11 days, and sporulated oocysts were 21.5 x 25.0 (20-23 x 24-26) microns with sporocysts 7.7 x 12.0 (6-8 x 10-13) microns. In P. boylii the prepatent period was 6-7 days, the patent period was 8-9 days, and sporulated oocysts were 20.1 x 23.2 (18-22 x 21-24) microns with sporocysts 6.8 x 10.0 (5-8 x 9-12) microns. Sporulated oocysts from both host species were used in direct side-by-side comparison of isozyme banding patterns using protein electrophoresis. The parasite has polytypic loci for leucine aminopeptidase (LAP), lactate dehydrogenase (LDH), and 6-phosphogluconate dehydrogenase (6-PGD). In oocysts from P. truei, LAP showed one band with fast migration and LDH and 6-PGD each showed two bands, one with fast and one with slow migration. In oocysts from P. boylii, LAP and LDH each had one band with slow migration and 6-PGD had one band with moderate migration. Oocysts of E. arizonensis collected from P. boylii were used to inoculate P. truei. The prepatent and patent periods, structural measurements, and isozyme banding patterns of the resultant oocysts were the same as those from P. truei when inoculated with oocysts from P. truei.

Fourth ventricle effects of nicotine, 2-methylpiperidine and cytisine in dogs.

Four distinguishable nicotinic binding sites have been identified as well as four nicotinic ligands with different specificities: (+/-)-2-methylpiperidine which binds to a very high affinity site (Site 1) and produces up-regulation of the high affinity site (Site 2); (-)-nicotine which binds to Site 1 and Site 2 as well as to a low affinity site (Site 4); (+)-nicotine which binds to Site 1, Site 4 and Site 3 which is also a high affinity site; and (-)-cytisine which binds to Sites 1 and 2. These drugs were injected into the 4th ventricle of 5 dogs in graded concentrations (12.5 to 400 micrograms) and their effects on the EEG, skin twitch reflex latency, heart rate, rectal temperature, pupillary diameter, blood pressure and the amplitude of the flexor reflex were measured. Drugs which act predominantly on Site 1 [(+/-)-2-methylpiperidine and (+)-nicotine] produced EEG synchronization and hyperalgesia while drugs which interact with Sites 2 and 4 produce EEG desynchronization, analgesia and tachycardia. These data indicate that nicotinic ligands which have different binding specificities have different actions in medullary function and support the hypothesis that the different binding sites have different pharmacologic significance.

Eimerians from different karyotypes of the Japanese wood mouse (Apodemus spp.), with descriptions of two new species and a redescription of Eimeria montgomeryae Lewis and Ball, 1983.

Examination of 131 wood mice (Apodemus spp.) representing 2 species and 6 subspecies collected from the Japanese islands of Hokkaido, Honshu, Kyushu, and Tsushima showed that 70 mice (53%) had coccidian oocysts in their feces. These included 21 of 42 (50%) Apodemus argenteus argenteus; 7 of 14 (50%) Apodemus argenteus hokkaidi; 2 of 3 (67%) Apodemus argenteus sagax; 3 of 9 (33%) Apodemus speciosus ainu; 36 of 61 (59%) Apodemus speciosus speciosus; and 1 of 2 (50%) Apodemus speciosus tusimaensis. Four distinct coccidians were identified: Eimeria argenteus n. sp. from A. a. argenteus, A. a. hokkaidi, A. a. sagax, and A. s. speciosus; Eimeria inuyamensis n. sp. from A. a. argenteus, A. s. speciosus, and A. s. tusimaensis; Eimeria montgomeryae Lewis and Ball, 1983, from A. a. argenteus, A. a. hokkaidi, A. a. sagax, A. s. ainu, and A. s. speciosus; and Eimeria uptoni Lewis and Ball, 1983, from A. a. argenteus, A. a. hokkaidi, and A. s. speciosus. Standard karyotypes were prepared from selected specimens of each host subspecies. All 3 subspecies of A. argenteus and A. s. tusimaensis have a 2n = 46; A. s. ainu, from Hokkaido, has a 2n = 48; and A. s. speciosus has at least 2 chromosomal races, 1 on northern (2n = 48) and 1 on southern (2n = 46) Honshu. Both chromosomal races of A. s. speciosus, as well as the other subspecies of Apodemus examined, shared their coccidian parasites freely.

An improved drug infusion pump for injecting nanoliter volumes subcortically in awake rats.

A new drug infusion pump capable of injecting nanoliter volumes of drug solution into the brains of awake rats has been constructed which incorporates a new "turntable" commutator and a compact tubing compressor mechanism requiring no gears. Injector cannulas inserted into guide cannulas permanently mounted in the rat's skull are connected to the drug pump by spring-protected, PE 10 tubing. Drug solutions are delivered when the pump rollers compress the drug-filled PE 10 tubing. An additional animal-activated switch and motorized mechanism rotates the drug pump in response to the animal's movements so that the PE 10 drug reservoir is not twisted. Testing the drug pump's performance in vivo with injections of 14C-nicotine into the caudate nucleus shows that drug delivery is both reliable and reproducible.